Letters, Testimony & Filings Groups Urge Secretary Becerra to License Competition on Diabetes and Weight Management Drugs September 23, 2024
Press Releases Three Facts to Know Before Novo Nordisk CEO Testifies at Senate Committee Hearing September 19, 2024
Fact Sheets & Backgrounders Key Facts to Know Before Novo Nordisk’s CEO Appears at the Senate HELP Committee September 17, 2024
Letters, Testimony & Filings Testimony Before the FDA’s Antimicrobial Drugs Advisory Committee Meeting about Sulopenem Etzadroxil/Probenecid for Uncomplicated Urinary Tract Infection September 9, 2024
Letters, Testimony & Filings Stakeholder comment to Reagan-Udall/FDA meeting regarding the treatment for PTSD September 6, 2024